Abstract: A method and system uses an open platform with an array of thermochromic sensors to generate a plurality of temperature data values of the sole of a foot. The method and system determine whether values produced by the temperature sensors indicate a pre-ulcer, ulcer, or both.

Abstract: An article is provided comprising a copolyester; wherein the copolyester comprises: a. at least one terephthalate monomer residue; b. about 85 to about 96 mole % of ethylene glycol residues; c. about 4 to about 15 mole % of a combination diethylene glycol (DEG) and at least one glycol residue selected from the group consisting of 1,4-cyclohexanedimethanol residues (CHDM), monopropylene glycol residues (MPG), and 2,2,4,4-tetramethyl-1,3-cyclobutane diol residues (TMCD); and d. a germanium catalyst present in the copolyester at a concentration of about 5 to about 500 ppm based on elemental germanium; wherein the diacid monomer is based on the substantially equal diacid equivalents of 100 mole % to diol equivalence of 100 mole % for a total of 200 mole %.

Abstract: A belt and a belt conveyor are provided for transporting particulate material and especially oilseeds up the belt conveyor. The belt conveyor can include an intake end having a hopper, a discharge end, a body extending between the intake end and the discharge end and a belt. The belt travels along a travel path in the belt conveyor; the belt traveling through the hopper, up an upper run in the body to the discharge end, down a return run in the body, and back through the hopper. The belt can have a top surface having pairs of adjacent ridges provided on the top surface, each ridge having a pair of arms extending from a point, in a travel direction of the belt, wherein each pair of adjacent ridges define a v-channel on the top surface of the belt.

Abstract: A process of producing an article by an extrusion blow molding manufacturing process is provided comprising: melting a copolyester in an extruder to produce a molten copolyester; extruding the molten copolyester through a die to form a tube of molten copolyester parison; clamping a mold having the desired finished shape around the parison; blowing air into the parison causing the parison to stretch and expand to fill the mold to produce a molded article; cooling the molded article; ejecting the article from the mold; and removing excess plastic from the article; wherein the copolyester comprises: at least one terephthalate monomer residue; ethylene glycol residues; a combination of diethylene glycol and at least one glycol residue selected from the group consisting of 1,4-cyclohexanedimethanol residues, monopropylene glycol residues, and 2,2,4,4-tetramethyl-1,3-cyclobutane diol residues; and a germanium catalyst present in the copolyester at a concentration of about 5 to about 500 ppm based on elemental germa

Abstract: A copolyester composition is provided comprising at least one copolyester and at least one polymeric component; wherein said copolyester comprises: a. terephthalate acid residues; b. about 85 to about 96 mole % of ethylene glycol residues; c. about 4 to about 15 mole % of a combination of diethylene glycol (DEG) residues and at least one glycol residue selected from the group consisting of 1,4-cyclohexanedimethanol residues (CHDM), monopropylene glycol residues (MPG), and 2,2,4,4-tetramethyl-1,3-cyclobutane diol residues (TMCD); and d. a germanium catalyst present in the copolyester at a concentration of about 5 to about 500 ppm based on elemental germanium; wherein the terephthalate monomer is based on the substantially equal diacid equivalents of 100 mole % to diol equivalence of 100 mole % for a total of 200 mole %.

Abstract: A load control system may include load control devices for controlling power provided to an electrical load. The load control devices may include a control-source device and a control-target device. The control-target device may control the power provided to the electrical load based on digital messages received from the control-source device. A user device may discover load control devices when the load control devices are within an established range associated with the user device. The user device and the load control devices may communicate via a wireless communications module. The established range may be adjusted based on the configurable transmit power of the user device or the wireless communications module associated with the user device. A discovered control-target device may be associated with a control-source device to enable the control-target device to control the power provided to the electrical load based on digital messages received from the control-source device.

Abstract: The specification relates to conjugates comprising a linker of Formula (IA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.

Abstract: A system including a delivery apparatus, a crimping device, and a loading assembly. The crimping device includes a housing disposed over a distal end portion of the delivery apparatus for receiving a radially expandable and compressible prosthetic heart valve. The housing includes a funnel segment, a pusher member, and an actuator releasably coupled to the pusher member. Movement of the actuator causes the pusher member to advance the prosthetic heart valve through the funnel segment for radially compressing at least a portion of the prosthetic heart valve. Compression of the prosthetic heart valve facilitates secure attachment of the prosthetic heart valve to the delivery apparatus. The loading assembly can include an additional funnel member for fully crimping and loading the prosthetic heart valve into the delivery apparatus for advancement through a patient's vasculature.

Abstract: The invention relates to a method of preparing an [18F] radio-labelled compound, wherein the water content is controlled. Controlling the water content and the origin of the water within the reaction process has a significant effect on both the yield and the purity of the product of the radio-labelling process.

Abstract: Provided herein is a catheter system including a catheter having a catheter distal end and a catheter proximal end, with the catheter defining a catheter lumen. The catheter system also includes a catheter hub coupled to the catheter proximal end, with the catheter hub further including a hub body having a hub distal end and a hub proximal end, the hub body having a cavity formed therein extending between the hub distal end and the hub proximal end. The catheter hub also includes an end port positioned at the hub proximal end and that provides an opening into the cavity. A split-septum connector of the catheter system is positioned at least partially within the end port, with the split-septum connector configured to seal the cavity when in a closed configuration and provide a fluid path to the catheter lumen when in an open configuration.

Abstract: A process to produce a copolyester is provided comprising: a. polymerizing 1) at least one terephthalate monomer; 2) about 85 to about 96 mole % of ethylene glycol; and 3) about 4 to about 15 mole % of a combination diethylene glycol (DEG) and at least one glycol residue selected from the group consisting of 1,4-cyclohexanedimethanol residues (CHDM), monopropylene glycol residues (MPG), and 2,2,4,4-tetramethy-1,3-cyclobutane diol residues (TMCD); in the presence of a germanium catalyst to produce the copolyester; wherein the germanium catalyst is present in the copolyester at a concentration of about 5 to about 500 ppm based on elemental germanium; wherein the diacid is based on the substantially equal diacid equivalents of 100 mole % to diol equivalence of 100 mole % for a total.

Abstract: Among other things, the present disclosure provides various useful agents. In some embodiments, provided agents can bind to beta-catenin. In some embodiments, the present disclosure provides technologies for modulating beta-catenin functions. In some embodiments, the present disclosure provides technologies for preventing and/or treating conditions, disorders or diseases associated with beta-catenin. In some embodiments, the present disclosure provides designed amino acids and agents which can provide improved properties and/or activities.